Suriname Meningitis Study
This study was initiated after the sudden increase in (viral) meningitis cases at the AZP. The aim of this study is to describe the epidemiology and clinical picture of viral meningitis in the AZP whilst improving diagnostic tools. This project is in collaboration with Erasmus Medical Center, Rotterdam, The Netherlands.
Artemisinine resistence of P. falciparum malaria in Suriname
The emerging resistance to artemisinin derivatives that has been reported in South-East Asia led us to assess the efficacy of artemether-lumefantrine as the first line therapy for uncomplicated Plasmodium falciparum infections in Suriname. The decreasing number of malaria cases in Suriname, which are currently limited to migrating populations and gold miners, precludes any conclusions on artemether efficacy because adequate numbers of patients are difficult to obtain. Therefore, a parasitaemia study is conducted to detect the emergence of resistance to artemether.
Management of HIV in Suriname
Management of HIV in Suriname; Treatment cascade & opportunistic infections. Collaboration with the Academic Medical Center, Amsterdam, The Netherlands.
Histoplasmosis in HIV positive adults
Histoplasmosis due to Histoplasma capsulatum var. capsulatum in the Guiana Shield and the French West Indies: Evaluating prevalence with a rapid diagnostic test using an ELISA capture method for the detection of Histoplasma antigens in blood and urine. Collaboration with the Clinical Investigation Center Clinical Epidemiology Inserm CIE802, French Guiana.
Hepatitis C prevalence in Suriname
Results from the Viral Hepatitis study among the Emergency Department population are in! We found a 1.0% prevalence of Hepatitis C. Interstingly only genotype 2 was identified in this population. Currently we are assessing the HBsAg, antiHBc prevalence and hepatitis B genotypes in the same population.